The FDA permitted Wilson-Cook Medical to market Hemospray, a new endoscopic device for the treatment of gastrointestinal bleeding.
The FDA approved Salix Pharmaceuticals’ Plenvu lower-volume polyethylene glycol-based bowel preparation.
Libertyville-based GI Partners of Illinois and Cumming, Ga.-based GI North both switched to the gGastro EHR system by gMed, a Modernizing Medicine company.
Olympus entered a co-development agreement with ai4gi to offer the artificial intelligence solution for real-time clinical decision support during screening and surveillance colonoscopy.
GI Supply’s Spot Ex Endoscopic Tattoo received CE mark approval and launched in Europe.
More articles on gastroenterology:
Hoag Orthopedic Institute hosts 1st mock surgery event — 5 highlights’
Envision to transition 95% of revenue in-network by the end of 2018
Envision blames ambulatory revenue drop on flu, sees Q2 recovery: 5 things to know from Q1
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
